ロード中...
Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial
PURPOSE: To examine associations between the UGT2B17 gene deletion and exemestane metabolites, and commonly reported side-effects (fatigue, hot flashes, and joint pain) among postmenopausal women participating in the MAP.3 chemoprevention trial. METHODS: The analytical samples for the UGT2B17 analys...
保存先:
| 出版年: | Breast Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7501182/ https://ncbi.nlm.nih.gov/pubmed/32715442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05812-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|